A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice

Douglas R Taupin and Mike Corbett
Med J Aust 2006; 185 (4): . || doi: 10.5694/j.1326-5377.2006.tb00544.x
Published online: 21 August 2006

To the Editor: The recent report by the Multicentre Australian Colorectal-neoplasia Screening (MACS) Group1 offered some intriguing findings. Participation in bowel cancer screening was lower than expected, despite a range of tests being offered. In addition, people offered a choice of different faecal occult blood tests (FOBTs) were less likely to participate than those not offered this choice. The accompanying editorial by Salkeld and colleagues concluded that “Informed consumers making smart choices about screening . . . would be a public health success”.2 We believe the available evidence indicates otherwise.

  • Douglas R Taupin
  • Mike Corbett

  • The Canberra Hospital, Garran, ACT.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.